BioSpace News Archive

Intellipharmaceutics Provides Operational Update - Jan. 24, 2018

The company provided an operational update on its plans and projected timelines for the 2018 year.

January 24, 2018
·
14 min read
Policy

CAO Group Protects its Diode Laser Patent Rights From Infringement by Biolase

CAO Group has filed patent infringement lawsuits in the United States District Court for the State of Utah and in the United States District Court for the Central District of California against Biolase.

January 24, 2018
·
2 min read
Promising Results From Study Show That Zero-Calorie Prebiotic Sweeteners Could Replace Sugar in Food and Drink Products

These results suggest that the natural, zero-calorie, healthy prebiotic sweeteners could work as bulk sugar replacements in a wide range of food and drink products.

January 24, 2018
·
3 min read
Pharm Country

Strongbridge Biopharma Plc Announces Proposed Public Offering of 5 Million Ordinary Shares

The offering is subject to market and other conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

January 24, 2018
·
4 min read
Business

Gastroenterology Associates, PC, Offers Patients Access to Clinical Research

By offering clinical trials as an option, the physicians at Gastroenterology Associates are able to introduce the latest advances in research to their patients.

January 24, 2018
·
1 min read
Biotech Bay

Ultragenyx Announces Pricing of Public Offering of Common Stock

The offering is expected to close on or about January 26, 2018, subject to satisfaction of customary closing conditions.

January 24, 2018
·
4 min read
Drug Development

MacroGenics Announces Continuation of SOPHIA Study of Margetuximab Based on Completion of Interim Futility Analysis

FDA grants Fast Track designation to margetuximab for treatment of metastatic breast cancer.

January 24, 2018
·
5 min read
Pharm Country

Stemline Therapeutics Prices $51.8M Public Offering of Common Stock

The offering is expected to close on January 26, 2018, subject to customary closing conditions.

January 24, 2018
·
4 min read
Policy

AngioDynamics Nabs FDA Fast Track for NanoKnife

FDA has granted the EAP designation to the Company’s NanoKnife System and proposed indication for use for the treatment of Stage III pancreatic cancer.

January 24, 2018
·
6 min read
Business

Anika Therapeutics Expands Strategic Collaboration with the Institute for Applied Life Sciences (IALS) at the University of Massachusetts Amherst to Develop Innovative Therapy for Rheumatoid Arthritis

In the next phase of this collaboration, Anika and UMass will focus on research to optimize the drug delivery system with the goal of advancing a novel therapeutic candidate into clinical trials to support regulatory submission.

January 24, 2018
·
6 min read